| Financial Year |
March 31 2023 |
| Monetary Funds |
1,387,527,241.52 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
2,233,408,726.06 |
| Accounts Receivable |
16,164,567,960.07 |
| Advances to Suppliers |
942,547,090.30 |
| Other Receivables |
609,744,789.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
6,186,953,579.93 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
211,359,569.21 |
| Total Current Assets |
30,450,054,079.65 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
11,617,310.22 |
| Investment Properties |
95,808,064.94 |
| Fixed Assetes |
1,193,258,416.17 |
| Under-construction Projects |
75,520,382.52 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
231,168,924.20 |
| R&D expenses |
-- |
| Goodwill |
72,166,924.65 |
| Long-Term Deferred and Prepaid Expenses |
42,716,957.89 |
| Deferred Income Tax Assets |
222,228,808.48 |
| Other Non-Current Assets |
1,671,802.17 |
| Sub-Total of Non-Current Assets |
2,407,625,913.09 |
| Total Assets |
32,857,679,992.74 |
| Short-Term Loans |
4,572,035,684.82 |
| Trading Financial liabilities |
-- |
| Notes Payable |
2,522,112,109.66 |
| Accounts Payable |
6,798,323,072.41 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
165,042,702.88 |
| Taxes Payable |
191,738,102.58 |
| Interest Payable |
-- |
| Dividend Payable |
38,012,670.02 |
| Other payables |
3,664,358,247.93 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,397,585,062.59 |
| Other Current Liabilities |
3,678,982,622.27 |
| Sub-Total of Current Liabilities |
23,160,572,200.30 |
| Long-term Loans |
2,300,158,300.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
59,032,623.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,793,506,444.98 |
| Total Liabilities |
25,954,078,645.28 |
| Paid-In Capital(Or Share Stock) |
1,310,315,012.00 |
| Capital Surplus |
2,432,983,967.50 |
| Surplus Reserve |
237,372,336.12 |
| LESS:Treasury Stock |
38,584,360.00 |
| Undistributed Profits |
2,128,860,481.17 |
| Minority Stockholder's Interest |
733,365,620.78 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,170,235,726.68 |
| Owner's Equity（Stockholder's Equity） |
6,903,601,347.46 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
32,857,679,992.74 |
